In the current study, the use of 1 nmol MC903 induced a slower AD development which manifested by a >7-fold lower level of TSLP in serum (≈1 ng/mL) day 7 (Figure 4f) as compared with the day 4 levels in the study by Li et al. 2006 [27]. Here, TSLP is linked to Alzheimer disease.